市場調查報告書
商品編碼
1530720
氧化鈰奈米顆粒的全球市場預測(~2030 年):按形式、應用、最終用戶和地區進行分析Cerium Oxide Nanoparticles Market Forecasts to 2030 - Global Analysis By Form, Application (Chemical Mechanical Planarization, Polishing Agent, Coatings, Energy Storage, Sunscreen Cosmetics, Catalyst and Other Applications), End User and by Geography |
2024年全球氧化鈰奈米粒子市場規模為9.2879億美元,預計2030年將達到29.7323億美元,預測期內複合年成長率為21.4%。
氧化鈰奈米顆粒(簡稱 CeO2 奈米顆粒)具有特殊的性質,使其可用於多種應用。由於它們能夠在 Ce3+ 和 Ce4+ 氧化態之間轉變,這些奈米顆粒以其促進氧化還原反應的高觸媒活性而聞名。它還在汽車觸媒轉換器中發揮重要作用,其卓越的儲氧能力可減少排放。
據美國化學會稱,奈米技術的進步徹底改變了材料科學,並在從醫學到能源儲存等領域實現了突破。
汽車觸媒轉換器的需求增加
奈米氧化鈰具有有效的儲氧和釋氧能力,廣泛應用於汽車觸媒轉換器。藉助此特性,氮氧化物和一氧化碳等有毒氣體可以轉化為氮氣和二氧化碳等毒性較小的排放氣體。此外,汽車產業專注於減少車輛排放氣體以遵守嚴格的環境法規,這導致對氧化鈰奈米顆粒的需求顯著增加。
擴充性和成本問題
以商業規模生產氧化鈰奈米粒子的高成本是主要障礙之一。高生產成本通常是由於合成品質和純度一致的奈米顆粒所需的複雜程序和專用設備造成的。此外,這可能會阻礙奈米顆粒的廣泛使用,特別是在預算緊張的市場和規模經濟至關重要的情況下。
生物醫學和醫療保健技術開發
氧化鈰奈米顆粒為醫療保健產業的新型治療方法、標靶藥物傳遞方法和診斷設備提供了前景。氧化鈰奈米顆粒的生物相容性和抗氧化特性使其特別適用於治療與氧化壓力相關的疾病、促進創傷治療和推進診斷成像方法。此外,進一步的研究可能會改善醫療保健結果和個人化醫療。
激烈的競爭與替代品
氧化鈰和其他奈米顆粒相關材料和技術是市場上的激烈競爭者,提供可比或更好的品質。材料科學和奈米技術的進步可能會帶來更經濟、更有效或更環保的替代方案。此外,根據市場和應用,對氧化鈰奈米顆粒的需求可能會減少。
氧化鈰奈米顆粒市場受到了 COVID-19 大流行的各種影響。最初,由於全球供應鏈和製造業務中斷,生產和分銷延遲影響了市場供應。汽車、電子和建築等大量使用氧化鈰奈米粒子的行業的需求因工業活動減少和許多國家實施的嚴格封鎖而進一步受到抑制。然而,隨著經濟逐漸復甦,需求增加,特別是在氧化鈰奈米粒子用於診斷和治療劑的醫療保健應用。
預計粉末細分市場在預測期內將是最大的
粉末部分通常在氧化鈰奈米粒子市場中佔據最大佔有率。粉末狀氧化鈰奈米粒子廣泛應用於各個行業,因為它們易於處理、用途廣泛,並且可以納入各種製造過程。鈰奈米顆粒廣泛應用於汽車觸媒轉換器中用於排放控制,其高表面積和催化性能非常重要。此外,粉狀氧化鈰奈米粒子由於其研磨性能和實現精細表面光潔度的能力,已在精密光學、電子和陶瓷的磨料中得到應用。
預計醫療保健領域在預測期內複合年成長率最高
在氧化鈰奈米顆粒市場中,醫療保健領域通常表現出最高的複合年成長率。這一成長是由專注於利用氧化鈰奈米顆粒進行生物醫學應用的研發活動的增加所推動的。在醫療保健領域,正在評估這些奈米顆粒的抗氧化特性、生物相容性以及在治療氧化壓力相關疾病和增強藥物傳輸系統方面的潛在治療效果。此外,它在診斷成像和生物標記檢測中的作用進一步推動了需求。
亞太地區通常在氧化鈰奈米粒子市場中佔據最大佔有率。中國、日本、韓國和印度等國家廣泛的工業活動,特別是汽車和電子產業,支持了這一優勢。這些國家強大的先進材料研發基礎設施使得氧化鈰奈米粒子在觸媒轉換器、電子拋光和其他工業應用中廣泛使用。此外,該地區龐大的市場佔有率主要歸因於醫療基礎設施投資的增加以及對尖端醫療技術的需求不斷成長。
北美氧化鈰奈米粒子市場的複合年成長率最高。研發投資的增加,特別是在環境和生物醫學應用方面的投資,是這項成長的主要驅動力。促進使用氧化鈰奈米粒子等尖端材料的創新和法律規範在北美受到好評。此外,該地區強勁的醫療保健產業和嚴格的環境法規創造了對清潔技術的需求,也推動了市場的成長。
According to Stratistics MRC, the Global Cerium Oxide Nanoparticles Market is accounted for $928.79 million in 2024 and is expected to reach $2973.23 million by 2030 growing at a CAGR of 21.4% during the forecast period. Cerium oxide nanoparticles, or CeO2 nanoparticles for short, have special qualities that make them useful for a range of applications. Because of their capacity to transition between the oxidation states of Ce3+ and Ce4+, these nanoparticles are well-known for their high catalytic activity, which promotes redox reactions. They also play a critical role in automobile catalytic converters, which reduce exhaust emissions owing to their remarkable oxygen storage capacity.
According to the American Chemical Society, advancements in nanotechnology have revolutionized materials science and enabled breakthroughs in fields ranging from medicine to energy storage.
Increasing demand for car catalytic converters
Due to their effective oxygen storage and release capabilities, cerium oxide nanoparticles are widely utilized in automotive catalytic converters. With the help of this characteristic, toxic gases like nitrogen oxides and carbon monoxide can be converted into less toxic emissions like nitrogen and carbon dioxide. Additionally, the heightened emphasis on vehicle emissions reduction by the automotive industry in order to comply with strict environmental regulations has led to a notable increase in the demand for cerium oxide nanoparticles.
Scalability and cost concerns
The high cost of producing cerium oxide nanoparticles on a commercial scale is one of the main obstacles. Higher production costs are often caused by the need for complex procedures and specialized equipment in the synthesis of nanoparticles with consistent quality and purity. Furthermore, this may prevent them from being widely used, especially in markets with tight budgets or in situations where economies of scale are essential.
Technological developments in biomedicine and healthcare
Cerium oxide nanoparticles present prospects for novel therapeutic treatments, targeted drug delivery methods, and diagnostic instruments in the healthcare industry. Their biocompatibility and antioxidant qualities are especially helpful in treating diseases linked to oxidative stress, promoting wound healing, and advancing imaging methods. Moreover, improved healthcare outcomes and personalized medicine may be possible with further research.
Severe rivalry and substitution
Cerium oxide and other nanoparticles-related materials and technologies are fierce competitors in the market, offering comparable or better qualities. Developments in materials science and nanotechnology could result in the creation of more economical, effective, or environmentally friendly alternatives. Additionally, in some markets and applications, this might lessen the need for cerium oxide nanoparticles.
The market for cerium oxide nanoparticles has experienced a variety of effects from the COVID-19 pandemic. Initially, delays in production and distribution had an impact on market availability due to disruptions in global supply chains and manufacturing operations. The demand from industries that use cerium oxide nanoparticles extensively, like the automotive, electronics, and construction sectors, was further suppressed by a reduction in industrial activity and strict lockdown measures implemented in many nations. However, demand increased as economies gradually recovered, especially in healthcare applications where cerium oxide nanoparticles are used in diagnostics and therapeutics.
The Powder segment is expected to be the largest during the forecast period
The powder segment typically holds the largest share in the cerium oxide nanoparticles market. Powdered cerium oxide nanoparticles are widely used across various industries due to their ease of handling, versatile applications, and ability to be integrated into different manufacturing processes. They are extensively employed in automotive catalytic converters for emissions control, where their high surface area and catalytic properties are crucial. Additionally, powdered cerium oxide nanoparticles find applications in polishing agents for precision optics, electronics, and ceramics due to their abrasive properties and ability to achieve fine surface finishes.
The Healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment typically exhibits the highest CAGR in the cerium oxide nanoparticles market. This growth is driven by increasing research and development activities focused on utilizing cerium oxide nanoparticles in biomedical applications. In healthcare, these nanoparticles are valued for their antioxidant properties, biocompatibility, and potential therapeutic benefits in treating oxidative stress-related diseases and enhancing drug delivery systems. Moreover, their role in diagnostic imaging and biomarker detection further boosts demand.
In the cerium oxide nanoparticle market, the Asia-Pacific region usually holds the largest share. Widespread industrial activity in nations like China, Japan, South Korea, and India, especially in the automotive and electronics industries, is what fuels this dominance. The extensive use of cerium oxide nanoparticles in catalytic converters, electronics polishing, and other industrial applications is made possible by these countries strong infrastructures for advanced material research and development. Furthermore, the region's substantial market share is also largely due to rising investments in healthcare infrastructure and rising demand for cutting-edge medical technologies.
The North American region has the highest CAGR in the cerium oxide nanoparticles market. Growing investments in R&D, especially in environmental and biomedical applications, are the main driver of this growth. Technological innovation and regulatory frameworks that facilitate the use of cutting-edge materials such as cerium oxide nanoparticles are highly valued in North America. Moreover, propelling market growth is the region's robust healthcare sector and strict environmental regulations that are creating a demand for cleaner technologies.
Key players in the market
Some of the key players in Cerium Oxide Nanoparticles market include Solvay, Nyacol Nano Technologies Inc., BASF, Advanced Nano Products Co., Ltd., Evonik Industries, Inframat Corporation, Strem Chemicals, Inc., Meliorum Technologies, Inc., Nanoshell, American Elements Inc, SkySpring Nanomaterials, Inc., Umicore, Cerion, LLC, Nanophase Technologies Corporation and Plasmachem GmbH.
In July 2024, BASF and ENGIE have signed a seven year biomethane purchase agreement (BPA). Under the BPA, ENGIE will supply BASF with 2.7 to 3.0 terawatt hours of biomethane throughout the term of the agreement. BASF uses certified biomethane at its Ludwigshafen,Germany and Antwerp,Belgium sites as a sustainable alternative to fossil raw materials in its manufacturing process.
In June 2024, Solvay, a leader in rare earth materials supply for catalysis and electronics, and Cyclic Materials, an advanced metals recycling company building a circular supply chain for rare earth elements and other critical metals, announced the signing of an agreement for the supply of recycled mixed rare earth oxide (rMREO) from Cyclic Materials to Solvay, with shipments to begin in late 2024.
In February 2024, Vattenfall and Evonik have inked new long-term electricity supply contracts, aiming to bolster Evonik's green energy consumption for chemical production. Commencing in 2025, two solar parks operated by Vattenfall in Schleswig-Holstein will furnish Evonik with approximately 120 gigawatt hours of solar power annually over a decade, under fixed conditions termed as "Power Purchase Agreements" (PPA).